Kimberly A. Selting

662 total citations · 1 hit paper
19 papers, 392 citations indexed

About

Kimberly A. Selting is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Genetics. According to data from OpenAlex, Kimberly A. Selting has authored 19 papers receiving a total of 392 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 5 papers in Surgery and 4 papers in Genetics. Recurrent topics in Kimberly A. Selting's work include Veterinary Oncology Research (7 papers), Virus-based gene therapy research (4 papers) and Advanced Radiotherapy Techniques (3 papers). Kimberly A. Selting is often cited by papers focused on Veterinary Oncology Research (7 papers), Virus-based gene therapy research (4 papers) and Advanced Radiotherapy Techniques (3 papers). Kimberly A. Selting collaborates with scholars based in United States, Hungary and Canada. Kimberly A. Selting's co-authors include Amy K. LeBlanc, David M. Vail, Christina Mazcko, Heidi B. Kellihan, Michelle L. Oblak, Erika P. Berger, Matthew J. Atherton, Laura E. Selmic, Jenna H. Burton and Sonja S. Tjostheim and has published in prestigious journals such as PLoS ONE, The FASEB Journal and Journal of Nutrition.

In The Last Decade

Kimberly A. Selting

16 papers receiving 368 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Veterinary Cooperative Oncology Group—Common Terminology Criteria for Adverse Events (VCOG‐CTCAE v2) following investigational therapy in dogs and cats

2021 177 citations Amy K. LeBlanc, Matthew J. Atherton et al. Veterinary and Comparative Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kimberly A. Selting United States	8	220	88	73	67	67	19	392
Keijiro Shiomitsu United States	10	225 1.0×	70 0.8×	61 0.8×	90 1.3×	43 0.6×	32	335
Lynn Griffin United States	11	242 1.1×	69 0.8×	82 1.1×	65 1.0×	28 0.4×	46	419
Guillermo Couto United States	9	326 1.5×	83 0.9×	78 1.1×	152 2.3×	92 1.4×	13	540
Joanne Tuohy United States	17	377 1.7×	111 1.3×	98 1.3×	174 2.6×	58 0.9×	41	574
Kaitlin M. Curran United States	13	398 1.8×	147 1.7×	85 1.2×	188 2.8×	67 1.0×	37	524
B.E. Powers United States	11	379 1.7×	105 1.2×	76 1.0×	134 2.0×	78 1.2×	23	544
Karine Araújo Damasceno Brazil	14	316 1.4×	58 0.7×	71 1.0×	158 2.4×	46 0.7×	47	475
Amy F. Pruitt United States	11	165 0.8×	86 1.0×	40 0.5×	60 0.9×	26 0.4×	14	455
Soumi Samuel India	4	302 1.4×	127 1.4×	31 0.4×	168 2.5×	37 0.6×	14	408
Maura G. O’Brien United States	9	313 1.4×	127 1.4×	61 0.8×	68 1.0×	20 0.3×	10	424

Countries citing papers authored by Kimberly A. Selting

Since Specialization

Citations

This map shows the geographic impact of Kimberly A. Selting's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimberly A. Selting with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimberly A. Selting more than expected).

Fields of papers citing papers by Kimberly A. Selting

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kimberly A. Selting. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimberly A. Selting. The network helps show where Kimberly A. Selting may publish in the future.

Co-authorship network of co-authors of Kimberly A. Selting

This figure shows the co-authorship network connecting the top 25 collaborators of Kimberly A. Selting. A scholar is included among the top collaborators of Kimberly A. Selting based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kimberly A. Selting. Kimberly A. Selting is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Cruz, J. Virgílio, et al.. (2025). Radiation Damage to a Three-Dimensional Hydrogel Model of the Brain Perivascular Niche. Tissue Engineering Part C Methods. 31(5). 181–190.

Basran, Parminder S., Michelle Turek, Kimberly A. Selting, & Nicholas J. Rancilio. (2024). AAPM WGVRTO report 390: A survey of veterinary radiation oncology equipment and infrastructure in 2022. Medical Physics. 51(6). 3924–3931. 1 indexed citations

Lattimer, Jimmy C., et al.. (2022). Clinical effectiveness and safety of intraarticular administration of a^117mTin radiocolloid (Synovetin OA^TM) for treatment of early and intermediate grade osteoarthritis of the elbow in a dose finding study conducted in 44 dogs. Veterinary Radiology & Ultrasound. 64(2). 351–359. 1 indexed citations

Marjanović, Marina, Janet E. Sorrells, Sixian You, et al.. (2022). Label-free optical redox ratio from urinary extracellular vesicles as a screening biomarker for bladder cancer.. PubMed. 12(5). 2068–2083. 9 indexed citations

Rowles, Joe L., Matthew A. Wallig, Kimberly A. Selting, et al.. (2021). A 10% Tomato Diet Selectively Reduces Radiation-Induced Damage in TRAMP Mice. Journal of Nutrition. 151(11). 3421–3430. 2 indexed citations

LeBlanc, Amy K., Matthew J. Atherton, R. Timothy Bentley, et al.. (2021). Veterinary Cooperative Oncology Group—Common Terminology Criteria for Adverse Events (VCOG‐CTCAE v2) following investigational therapy in dogs and cats. Veterinary and Comparative Oncology. 19(2). 311–352. 177 indexed citations breakdown →

Kirk, Natalie M., et al.. (2020). The Effect of Glutathione on Itraconazole‐Associated Hepatocyte Toxicity in an In Vitro Canine Model. The FASEB Journal. 34(S1). 1–1. 1 indexed citations

Wendt, Richard E., et al.. (2020). Radiation Safety Considerations in the Treatment of Canine Skeletal Conditions Using 153Sm, 90Y, and 117mSn. Health Physics. 118(6). 702–710. 5 indexed citations

Fan, Timothy M. & Kimberly A. Selting. (2019). Exploring the Potential Utility of Pet Dogs With Cancer for Studying Radiation-Induced Immunogenic Cell Death Strategies. Frontiers in Oncology. 8. 680–680. 16 indexed citations

10.

Lattimer, Jimmy C., et al.. (2019). Intraarticular injection of a Tin‐117 m radiosynoviorthesis agent in normal canine elbows causes no adverse effects. Veterinary Radiology & Ultrasound. 60(5). 567–574. 16 indexed citations

11.

Zhang, Ti, Shuang Cai, Chad E. Groer, et al.. (2016). Hyaluronan-Lysine Cisplatin Drug Carrier for Treatment of Localized Cancers: Pharmacokinetics, Tolerability, and Efficacy in Rodents and Canines. Journal of Pharmaceutical Sciences. 105(6). 1891–1900. 7 indexed citations

12.

Cai, Shuang, Ti Zhang, Qiuhong Yang, et al.. (2016). Phase I-II clinical trial of hyaluronan-cisplatin nanoconjugate in dogs with naturally occurring malignant tumors. American Journal of Veterinary Research. 77(9). 1005–1016. 16 indexed citations

13.

Paoloni, Melissa, Christina Mazcko, Kimberly A. Selting, et al.. (2015). Defining the Pharmacodynamic Profile and Therapeutic Index of NHS-IL12 Immunocytokine in Dogs with Malignant Melanoma. PLoS ONE. 10(6). e0129954–e0129954. 40 indexed citations

14.

Wendt, Richard E., et al.. (2015). Radiation safety restrictions in the radionuclide treatment of canine osteosarcoma. 56. 1226–1226.

15.

Chanda, Nripen, Anandhi Upendran, Evan Boote, et al.. (2013). Gold Nanoparticle Based X-Ray Contrast Agent for Tumor Imaging in Mice and Dog: A Potential NanoPlatform for Computer Tomography Theranostics. Journal of Biomedical Nanotechnology. 10(3). 383–392. 31 indexed citations

16.

Selting, Kimberly A., Jimmy C. Lattimer, Carolyn J. Henry, et al.. (2012). Evaluation of a B-cell leukemia-lymphoma 2-specific radiolabeled peptide nucleic acid–peptide conjugate for scintigraphic detection of neoplastic lymphocytes in dogs with B-cell lymphoma. American Journal of Veterinary Research. 73(5). 681–688. 7 indexed citations

17.

Lattimer, Jimmy C., et al.. (2011). Treatment of a Malignant Pheochromocytoma in a Dog Using 131I Metaiodobenzylguanidine. Journal of the American Animal Hospital Association. 47(6). e188–e194. 7 indexed citations

18.

Nagata, Koichi, et al.. (2010). ⁹⁰Sr THERAPY FOR ORAL SQUAMOUS CELL CARCINOMA IN TWO CATS. Veterinary Radiology & Ultrasound. 52(1). 114–117. 4 indexed citations

19.

Northrup, Nicole C., Kimberly A. Selting, Kenneth M. Rassnick, et al.. (2006). Outcomes of Cats With Oral Tumors Treated With Mandibulectomy: 42 Cases. Journal of the American Animal Hospital Association. 42(5). 350–360. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact